Evidence map›Paper›PMID 33240425›Full record

ArticleOncology letters2021

Epithelial-mesenchymal transition and metastatic ability of CD133

Masamichi Okada, Kazushige Kawai, Hirofumi Sonoda, Hiroshi Shiratori, Junko Kishikawa, Hiroshi Nagata, Hiroaki Nozawa, Kazuhito Sasaki, Manabu Kaneko, Koji Murono and 7 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Masamichi OkadaDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Kazushige KawaiDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Hirofumi SonodaDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Hiroshi ShiratoriDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Junko KishikawaDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Hiroshi NagataDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Hiroaki NozawaDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Kazuhito SasakiDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Manabu KanekoDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Koji MuronoDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Shigenobu EmotoDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Yuuki IidaDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Hiroaki IshiiDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Yuichiro YokoyamaDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Hiroyuki AnzaiDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
Kiyoshi HasegawaHepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo 113-8655, Japan.
Soichiro IshiharaDepartment of Surgical Oncology, The University of Tokyo, Tokyo 113-8655, Japan.
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although CD133 is a representative cancer stem cell marker, its function in tumor aggressiveness under hypoxia remains unclear. Therefore, the present study aimed to investigate the associations between CD133, the epithelial-mesenchymal transition and distant metastasis in colorectal cancer. CD133

Indexed as

CD133colorectal cancerepithelial-mesenchymal transitionhypoxiametastasis

Identifiers

PMID33240425
PMCPMC7681219
OpenAlexW3103609671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.